Heart transplantation in women with dilated cardiomyopathy

Transplantation

Volumn 89, Issue 2, 2010, Pages 236-244

  Regitz Zagrosek, Vera ^a,b   Petrov, George ^a,b   Lehmkuhl, Elke ^a,b   Smits, Jaqueline M ^c   Babitsch, Birgit ^d   Brunhuber, Claudia ^a   Jurmann, Beate ^b   Stein, Julia ^b   Schubert, Carola ^a   Merz, Noel Bairey ^e   Lehmkuhl, Hans Brendan ^b   Hetzer, Roland ^b  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Dilated cardiomyopathy; Gender; Heart failure; Heart transplant outcome; Heart transplantation

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; EUROPE; EXERCISE TOLERANCE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; CARDIOMYOPATHY, DILATED; COHORT STUDIES; CREATININE; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OXYGEN CONSUMPTION; PATIENT SELECTION; PROSPECTIVE STUDIES; PULMONARY VENTILATION; SEX CHARACTERISTICS;

EID: 76649086694     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c35255     Document Type: Article

References (54)

1. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme-A surveyon the qualityofcare among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442.
2. O'Meara E, Clayton T, McEntegart MB, et al. Sex differences in clinical characteristics and prognosisinabroad spectrum ofpatients with heart failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 115: 3111.
3. Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004; 88: 1321, xii.
4. Adams KF Jr, Sueta CA, Gheorghiade M, et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 1999; 99: 1816.
5. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993; 22(4 suppl A): 6A.
6. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107.
7. Petrie MC, Dawson NF, Murdoch DR, et al. Failure of women's hearts. Circulation 1999; 99: 2334.
8. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251.
9. Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction.Prog Cardiovasc Dis2007; 49: 241.
10. Regitz-ZagrosekV, Lehmkuhl E, Lehmkuhl HB, et al. Gender aspects in heart failure. Pathophysiology and medical therapy. Arch Mal Coeur Vaiss 2004; 97: 899.
11. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006; 5: 425.
12. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, et al. Management of patients with heart failure in clinical practice: Differences between men and women. Heart 2008; 94: e10.
13. De Maria R, Gavazzi A, Recalcati F, et al. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am J Car-diol 1993; 72: 580.
14. Aaronson KD, Schwartz JS, Goin JE, et al. Sex differences in patient acceptance of cardiac transplant candidacy. Circulation 1995; 91: 2753.
15. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397.
16. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: A study of 737 consecutive patients. J Am Coll Cardiol 1995; 26: 1417.
17. Taylor DO, Edwards LB, Boucek MM, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004; 23: 796.
18. Coughlin SS, Comstock GW, Baughman KL. Descriptive epidemiology of idiopathic dilated cardiomyopathy in Washington County, Maryland, 1975-1991. J Clin Epidemiol 1993; 46: 1003.
19. Regitz-Zagrosek V, Hocher B, Bettmann M, et al. {alpha}2C-Adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy. Eur Heart J 2006; 27: 454.
20. Friedrichs F, Zugck C, Rauch GJ, et al. HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy. Genome Res 2008; 19: 395.
21. Komoda T, Hetzer R, Lehmkuhl HB. Influence of new Eurotransplant heart allocation policy on outcome of heart transplant candidates in Germany. J Heart Lung Transplant 2008; 27: 1108.
22. Smits JM, Vanhaecke J, Haverich A, et al. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eu-rotransplant, 1997-1999. Clin Transpl 2003: 89.
23. Komoda T, Drews T, Lehmkuhl HB, et al. Role of ventricular assist devices in the German heart allocation system. J Artif Organs 2006; 9: 29.
24. Komoda T, Hetzer R, Lehmkuhl HB. Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system. Eur J Cardiothorac Surg 2008; 34: 301; discussion 306.
25. Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005; 112(9 suppl): I37.
26. Potapov EV, Loforte A, Weng Y, et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg 2008; 23: 185.
27. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980; 62: 1054.
28. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomo-graphic assessment offunctional aerobic impairment in cardiovascular disease. Am Heart J 1973; 85: 546.
29. Habedank D, Reindl I, Vietzke G, et al. Ventilatory efficiency and exercise tolerance in 101 healthy volunteers. Eur J Appl Physiol Occup Physiol 1998; 77: 421.
30. Muller J, Wallukat G, Dandel M, et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385.
31. Gillum RF. Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 1986; 111: 752.
32. Codd MB, Sugrue DD, Gersh BJ, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989; 80: 564.
33. Bagger JP, Baandrup U, Rasmussen K, et al. Cardiomyopathy in western Denmark. Br Heart J 1984; 52: 327.
34. Arola A, Jokinen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997; 146: 385.
35. Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007; 39: 91.
36. Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: Insights from the BEST study. J Am Coll Cardiol 2003; 42: 2128.
37. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182.
38. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305.
39. Baumhakel M, Muller U, Bohm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009; 11: 299.
40. Myers J, Arena R, Dewey F, et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008; 156: 1177.
41. Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129: 286.
42. Hiemann NE, KnosallaC, WellnhoferE, et al. Beneficial effect offemale gender on long-term survival after heart transplantation. Transplantation 2008; 86: 348.
43. Weiss ES, Allen JG, Patel ND, et al. The impact of donor-recipient sex matchingon survival following orthotopic heart transplantation: Analysis of 18, 000 transplants in the modern era. Circ Heart Fail 2009; 2: 401.
44. Benjamin EJ, LevyD, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840.
45. Hsich E, Chadalavada S, Krishnaswamy G, et al. Long-term prognostic value of peak oxygen consumption in women versus men with heart failure and severely impaired left ventricular systolic function. Am J Cardiol 2007; 100: 291.
46. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The An-Ticoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005; 112: 1687.
47. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. JAutoimmun 2007; 28: 1.
48. Verthelyi D, Ahmed SA. 17-/3-Estradiol, but not 5 alpha- dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology 1994; 135: 2615.
49. Gubbels MR, Jorgensen TN, Metzger TE, et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. J Immunol 2005; 175: 6190.
50. Morganti S, Ceda GP, Saccani M, et al. Thyroid disease in the elderly: Sex-related differences in clinical expression. J Endocrinol Invest 2005; 28(11 suppl proceedings): 101.
51. Stork S, Boivin V, Horf R, et al. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006; 152: 697.
52. Christ T, Wettwer E, Dobrev D, et al. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomy-ocytes. JMol Cell Cardiol 2001; 33: 1515.
53. Jahns R, Boivin V, Siegmund C, et al. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999; 99: 649.
54. Iwata M, Yoshikawa T, Baba A, et al. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37: 418.